Detalhe da pesquisa
1.
Scabies in French Guiana: Quantitative and qualitative factors associated with therapeutic failure.
J Eur Acad Dermatol Venereol
; 38(3): 602-612, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041562
2.
[The interplay between isolation and precariousness, and hospitalization duration in French Guiana]. / Calcul de l'IP-DMS en Guyane : prendre en compte le poids réel de la précarité et de l'isolement.
Rev Epidemiol Sante Publique
; 68(2): 125-132, 2020 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-32035728
3.
High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study.
Epidemiol Infect
; 145(6): 1276-1284, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28091335
4.
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial.
Br J Cancer
; 110(5): 1148-54, 2014 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-24407191
5.
Pathological response and safety of two neoadjuvant strategies with bevacizumab in MRI-defined locally advanced T3 resectable rectal cancer: a randomized, noncomparative phase II study.
Ann Oncol
; 25(11): 2205-2210, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122693
6.
Masitinib in advanced gastrointestinal stromal tumor (GIST) after failure of imatinib: a randomized controlled open-label trial.
Ann Oncol
; 25(9): 1762-1769, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25122671
7.
A dose-escalating phase I of imatinib mesylate with fixed dose of metronomic cyclophosphamide in targeted solid tumours.
Br J Cancer
; 109(10): 2574-8, 2013 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24149182
8.
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trial.
Ann Oncol
; 24(4): 1087-93, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23175622
9.
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II study.
Br J Cancer
; 107(3): 435-41, 2012 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-22767144
10.
Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.
Ann Oncol
; 23(4): 919-27, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21825101
11.
Paid HIV rapid testing in general medicine private practice in French Guiana: a pilot project.
Public Health
; 151: 23-26, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28704721
12.
Phase II randomised trial of chemoradiotherapy with FOLFOX4 or cisplatin plus fluorouracil in oesophageal cancer.
Br J Cancer
; 103(9): 1349-55, 2010 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-20940718
13.
Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer.
Br J Cancer
; 102(1): 59-67, 2010 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-19920832
14.
Megestrol acetate versus metronomic cyclophosphamide in patients having exhausted all effective therapies under standard care.
Br J Cancer
; 102(8): 1207-12, 2010 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-20354522
15.
Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS).
Eur J Cancer
; 111: 12-20, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30798084
16.
Factors favouring palliative treatment multidisciplinary decisions for newly diagnosed visceral and soft tissue sarcomas.
Clin Oncol (R Coll Radiol)
; 20(7): 523-7, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18440792
17.
[GIST: imaging findings]. / GIST: rôle de l'imagerie.
J Chir (Paris)
; 145 Suppl 3: 6S12-7, 2008.
Artigo
em Francês
| MEDLINE | ID: mdl-19060843
18.
[Not Available]. / GIST : rôle de l'imagerie.
J Chir (Paris)
; 145S3: 6S12-7, 2008.
Artigo
em Francês
| MEDLINE | ID: mdl-22793865
19.
An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.
Eur J Cancer
; 103: 17-23, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30196106
20.
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer.
Ann Oncol
; 18(12): 2000-5, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17785765